References : Platelet-rich fibrin prepared from stored whole-blood samples [2]
Duan X, Bradbury SR, Olsen BR, Berendsen AD. Matrix Biol. 2016;52-54:127–40.
Kawase T, Okuda K, Kogami H, Nakayama H, Nagata M, Nakata K, Yoshie H. Characterization of human cultured periosteal sheets expressing bone-forming potential: in vitro and in vivo animal studies. J Tissue Eng Regen Med. 2009;3:218–29.
Kawase T, Hayama K, Tsuchimochi M, Nagata M, Okuda K, Yoshie H, Burns DM, Nakata K. Evaluating the safety of somatic periosteal cells by flow-cytometric analysis monitoring the history of DNA damage. Biopreserv Biobank. 2016;14:129–37.
Horimizu M, Kawase T, Nakajima Y, Okuda K, Nagata M, Wolff LF, Yoshie H. An improved freeze-dried PRP-coated biodegradable material suitable for connective tissue regenerative therapy. Cryobiology. 2013;66:223–32.
de Wildt-Eggen J, Schrijver JG, Bouter-Valk HJ, Fijnheer R, Bins M, van Prooijen HC. Improvement of platelet storage conditions by using new polyolefin containers. Transfusion. 1997;37:476–81.
Murphy S, Rebulla P, Bertolini F, Holme S, Moroff G, Snyder E, Stromberg R. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev. 1994;8:29–36.
Sonker A, Dubey A. Determining the effect of preparation and storage: an effort to streamline platelet components as a source of growth factors for clinical application. Transfus Med Hemother. 2015;42:174–80.
Hogman CF, Gong J, Hambraeus A, Johansson CS, Eriksson L. The role of white cells in the transmission of Yersinia enterocolitica in blood components. Transfusion. 1992;32:654–7.
Pietersz RN, Reesink HW, Pauw W, Dekker WJ, Buisman L. Prevention of Yersinia enterocolitica growth in red-blood-cell concentrates. Lancet. 1992;340:755–6.
Serial posts:
- Background : Platelet-rich fibrin prepared from stored whole-blood samples
- Methods : Platelet-rich fibrin prepared from stored whole-blood samples [1]
- Methods : Platelet-rich fibrin prepared from stored whole-blood samples [2]
- Methods : Platelet-rich fibrin prepared from stored whole-blood samples [3]
- Results : Platelet-rich fibrin prepared from stored whole-blood samples
- Discussion : Platelet-rich fibrin prepared from stored whole-blood samples [1]
- Discussion : Platelet-rich fibrin prepared from stored whole-blood samples [2]
- Conclusions : Platelet-rich fibrin prepared from stored whole-blood samples
- Abbreviations : Platelet-rich fibrin prepared from stored whole-blood samples
- References : Platelet-rich fibrin prepared from stored whole-blood samples [1]
- References : Platelet-rich fibrin prepared from stored whole-blood samples [2]
- Author information : Platelet-rich fibrin prepared from stored whole-blood samples [1]
- Author information : Platelet-rich fibrin prepared from stored whole-blood samples [2]
- Additional information : Platelet-rich fibrin prepared from stored whole-blood samples
- Rights and permissions : Platelet-rich fibrin prepared from stored whole-blood samples
- About this article : Platelet-rich fibrin prepared from stored whole-blood samples
- Fig. 1. Glucose levels (a), calcium levels (b), and pH (c) of stored WB samples. Supernatant serum fractions were examined. Plasma fractions prepared by quick centrifugation were used to determine calcium levels in fresh and stored WB samples that were not added CaCl2. N = 6 : Platelet-rich fibrin prepared from stored whole-bl
- Fig. 2. Appearance of PRF clots prepared from WB samples stored for 2 days. These observations are representative of WB samples obtained from four donors : Platelet-rich fibrin prepared from stored whole-bl
- Fig. 3. SEM examination of fibrin fibers formed in self-clotted PRF and thrombin-stimulated PPP clots. PRF was prepared from fresh and 2-day-old WB samples. Similar observations were obtained from WB samples collected from three other donors. Scale bars = 10 μm : Platelet-rich fibrin prepared from stored whole-bl
- Fig. 4. Bioactivities and PDGF-BB concentrations in PRF extracts and the supernatant serum fraction. a PRF extracts were added to periosteal cell cultures and incubated for 3 days to evaluate their effects on cell proliferation. No significant differences were observed among three groups. b PRF extracts were subjected to measurement of PDGF-BB levels using an ELISA kit. No significant differences were observed in the supernatant among three groups. N = 6. c Representative localization of supernatant serum fraction of PRF preparation just after centrifugation : Platelet-rich fibrin prepared from stored whole-bl